Hughes, C., Cho, S.-G., Mahalaxmi, I., Subramaniam, M. D., Vellingiri, B., & Warren, S. (2022). Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials. In The Coronavirus Pandemic and the Future Volume 1: Virology, Epidemiology, Translational Toxicology and Therapeutics. London, UK: The Royal Society of Chemistry.

Hughes, Claude, Ssang-Goo Cho, Iyer Mahalaxmi, Mohana Devi Subramaniam, Balachandar Vellingiri, and Stafford Warren. “Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials.” In The Coronavirus Pandemic and the Future Volume 1: Virology, Epidemiology, Translational Toxicology and Therapeutics. London, UK: The Royal Society of Chemistry, 2022.

Hughes C, Cho S-G, Mahalaxmi I, Subramaniam MD, Vellingiri B, Warren S. Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials. In: The Coronavirus Pandemic and the Future Volume 1: Virology, Epidemiology, Translational Toxicology and Therapeutics. London, UK: The Royal Society of Chemistry; 2022.

Hughes, Claude, et al. “Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials.” The Coronavirus Pandemic and the Future Volume 1: Virology, Epidemiology, Translational Toxicology and Therapeutics, The Royal Society of Chemistry, 2022.

Hughes C, Cho S-G, Mahalaxmi I, Subramaniam MD, Vellingiri B, Warren S. Therapeutic Options Initially Available for COVID-19 Patients and Initial Clinical Trials. The Coronavirus Pandemic and the Future Volume 1: Virology, Epidemiology, Translational Toxicology and Therapeutics. London, UK: The Royal Society of Chemistry; 2022.